BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18778462)

  • 1. In GFP with high risk HPV-18E6 fusion protein expressed 293T and MCF-7 cells, the endogenous wild-type p53 could be transiently phosphorylated at multiple sites.
    Sun L; Zhang G; Li Z; Song T; Huang C; Si L
    J Exp Clin Cancer Res; 2008 Sep; 27(1):35. PubMed ID: 18778462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV-16E6 can induce multiple site phosphorylation of p53.
    Zhang G; Sun L; Li Z; Si L; Song T; Huang C; Zhang W
    Oncol Rep; 2009 Feb; 21(2):371-7. PubMed ID: 19148510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The location of endogenous wild-type p53 protein in 293T and HEK293 cells expressing low-risk HPV-6E6 fusion protein with GFP.
    Sun L; Shen X; Liu Y; Zhang G; Wei J; Zhang H; Zhang E; Ma F
    Acta Biochim Biophys Sin (Shanghai); 2010 Mar; 42(3):230-5. PubMed ID: 20213049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GFP/HPV-16E6 fusion protein induces apoptosis in MCF-7 and 293T cells using a transient expression system.
    Zhang G; Liu Y; Yu L; Sun L
    Oncol Rep; 2012 Nov; 28(5):1673-80. PubMed ID: 22922869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular distribution of tumour suppressor protein p53 and high-risk human papillomavirus (HPV)-18 E6 fusion protein in wild-type p53 cell lines.
    Sun L; Zhang G; Li Z; Lei T; Huang C; Song T; Si L
    J Int Med Res; 2008; 36(5):1015-21. PubMed ID: 18831896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two different HPV-11E6 fusion proteins trap p53 in the cytoplasm and induce apoptosis.
    Sun L; Zhang G; Lei T; Huang C; Song T; Si L
    Cancer Biol Ther; 2008 Dec; 7(12):1909-15. PubMed ID: 18981731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53.
    Stewart D; Ghosh A; Matlashewski G
    J Virol; 2005 Jul; 79(14):8773-83. PubMed ID: 15994771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of p53 DNA binding by human papillomavirus E6 proteins.
    Lechner MS; Laimins LA
    J Virol; 1994 Jul; 68(7):4262-73. PubMed ID: 8207801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites.
    Das KC; Dashnamoorthy R
    Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L87-97. PubMed ID: 12959929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
    Thatte J; Banks L
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2.
    Muschik D; Braspenning-Wesch I; Stockfleth E; Rösl F; Hofmann TG; Nindl I
    PLoS One; 2011; 6(11):e27655. PubMed ID: 22110707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling of DNA damage is not sufficient to induce p53 response: (re)activation of wt p53 protein strongly depends on cellular context.
    Wesierska-Gadek J; Gueorguieva M; Komina O; Schmid G; Kramer MP
    J Cell Biochem; 2008 Apr; 103(5):1607-20. PubMed ID: 17879942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stranglehold on the spindle assembly checkpoint: the human papillomavirus E2 protein provokes BUBR1-dependent aneuploidy.
    Tan CL; Teissier S; Gunaratne J; Quek LS; Bellanger S
    Cell Cycle; 2015; 14(9):1459-70. PubMed ID: 25789401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines.
    Liang XH; Volkmann M; Klein R; Herman B; Lockett SJ
    Oncogene; 1993 Oct; 8(10):2645-52. PubMed ID: 8397367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta Human Papillomavirus 8E6 Attenuates LATS Phosphorylation after Failed Cytokinesis.
    Dacus D; Cotton C; McCallister TX; Wallace NA
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32238586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
    Zhao H; Traganos F; Darzynkiewicz Z
    Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk human papillomavirus E6 protein has two distinct binding sites within p53, of which only one determines degradation.
    Li X; Coffino P
    J Virol; 1996 Jul; 70(7):4509-16. PubMed ID: 8676476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Human Papillomavirus E6 PDZ Binding Motif Links DNA Damage Response Signaling to E6 Inhibition of p53 Transcriptional Activity.
    Thatte J; Massimi P; Thomas M; Boon SS; Banks L
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29848585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.